60 stories tagged with #therapeutics, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Therapeutics"
Kymera Therapeutics director Bruce Booth sells $34.8m in shares
Kymera Therapeutics director Bruce Booth sells $44m in shares
Form 4 Kymera Therapeutics Inc For: 25 June
Form 4 Kymera Therapeutics Inc For: 25 June
Coiled Therapeutics establishes medical advisory board
Apogee Therapeutics, Inc. (APGE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Apogee Therapeutics, Inc. (APGE) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 10, 2026 9:20 AM EDTCompany ParticipantsJane Pritchett...…
Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188%
Sionna Therapeutics, Inc. (SION) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Sionna Therapeutics, Inc. (SION) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 10, 2026 10:00 AM EDTCompany ParticipantsMichael Cloonan -...…
Capricor Therapeutics, Inc. (CAPR) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Capricor Therapeutics, Inc. (CAPR) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 10, 2026 10:00 AM EDTCompany ParticipantsLinda Marbán -...…
Heron Therapeutics In A Tough Spot After Cinvanti Court Loss (Rating Downgrade)
Heron Therapeutics hit as court invalidates key Cinvanti patents; Zynrelef can’t offset losses.…
Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
4D Molecular Therapeutics, Inc. (FDMT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
4D Molecular Therapeutics, Inc. (FDMT) Jefferies Global Healthcare Conference 2026 June 3, 2026 3:10 PM EDTCompany ParticipantsDavid Kirn - Co-Founder,...…
Denali Therapeutics Inc. (DNLI) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Denali Therapeutics Inc. (DNLI) Jefferies Global Healthcare Conference 2026 June 4, 2026 8:45 AM EDTCompany ParticipantsRyan Watts - Co-Founder, President,...…
Tenaya Therapeutics, Inc. (TNYA) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
Tenaya Therapeutics, Inc. (TNYA) Jefferies Global Healthcare Conference 2026 June 4, 2026 3:10 PM EDTCompany ParticipantsFaraz Ali - CEO, Interim Principal...…
Spyre Therapeutics CFO Scott Burrows sells $532,936 in stock
Spyre Therapeutics CMO Sheldon Sloan sells $624,975 in stock
CRISPR Therapeutics AG (CRSP) Presents at Jefferies Global Healthcare Conference 2026 Transcript
CRISPR Therapeutics AG (CRSP) Jefferies Global Healthcare Conference 2026 June 3, 2026 9:55 AM EDTCompany ParticipantsSamarth Kulkarni - CEO &...…
United Therapeutics Corporation (UTHR) Presents at Jefferies Global Healthcare Conference 2026 Transcript
United Therapeutics Corporation (UTHR) Jefferies Global Healthcare Conference 2026 June 3, 2026 12:45 PM EDTCompany ParticipantsJames Edgemond - CFO &...…
The Prognosis For Palvella Therapeutics
Palvella Therapeutics stock has surged, driven by strong results for its microcystic lymphatic malformations treatment. Read more on PVLA stock here.…
Karyopharm Therapeutics Inc. (KPTI) Discusses Phase III SENTRY Trial Results of Selinexor Plus Ruxolitinib in Myelofibrosis Transcript
Karyopharm Therapeutics Inc. (KPTI) Discusses Phase III SENTRY Trial Results of Selinexor Plus Ruxolitinib in Myelofibrosis June 2, 2026 2:00 PM EDTCompany...…
CRISPR Therapeutics Stock Is Absurdly Cheap -- Here's Why Analysts See 437% Upside Potential
Tenaya Therapeutics, Inc. (TNYA) Discusses Interim Data from MyPEAK-1 Trial of TN-201 Gene Therapy for MYBPC3-Associated HCM Transcript
Tenaya Therapeutics, Inc. (TNYA) Discusses Interim Data from MyPEAK-1 Trial of TN-201 Gene Therapy for MYBPC3-Associated HCM June 3, 2026 8:00 AM EDTCompany...…
Trevi Therapeutics Is Up 100%, Pivotal bioVenture Adds Anyway. Here's Why That Matters.
Eli Lilly signs $1.9B gene-editing deal with Ascidian Therapeutics
Tenaya Therapeutics, Inc. (TNYA) Discusses Interim Data from MyPEAK-1 Trial of TN-201 Gene Therapy for MYBPC3-Associated HCM - Slideshow
2026-06-03. The following slide deck was published by Tenaya Therapeutics, Inc.…
Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Genetically modified hookworms produce and deliver therapeutics
Hookworms, intestinal parasites that infect hundreds of millions of people in under-resourced tropical regions around the globe, have evolved to survive inside the human gut for ye…
Form 144 Axsome Therapeutics For: 2 June
Form DEF 14A TRANSCODE THERAPEUTICS For: 2 June
STAT+: Servier to buy Edgewise Therapeutics’ muscular dystrophy drug
The French pharma firm Servier is buying an experimental muscular dystrophy drug from Edgewise Therapeutics for $1.55 billion upfront.…
Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the 2026 American Society of Clinical Oncology Annual Meeting - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge
United Therapeutics Corporation (UTHR): Renaissance Technologies Likes This Biotech Stock
Dianthus Therapeutics: A Financed Autoimmune Platform With More Than One Way To Win
Dianthus Therapeutics is positioned as a category-expanding biotech, leveraging convenience and safety. Find out why DNTH stock is a buy.…
OrbiMed Advisors, director, sells $4,493 in Sionna Therapeutics stock
Sionna Therapeutics director Peter Thompson sells $4,493 of shares
Form 144 Sionna Therapeutics For: 29 May
Werewolf Therapeutics director Luke Evnin sells $66,200 in shares
Corcept Therapeutics chief accounting officer sells $325,000 in stock
Form 13G Avalo Therapeutics For: 29 May
Form 144 C4 Therapeutics For: 28 May
Rein Therapeutics director buys $49,560 in company stock
Polaryx Therapeutics CEO’s Mstone buys $360,003 in PLYX stock
Dyne therapeutics director Brian Posner buys $36,420 in stock
Apogee Therapeutics: Charging Toward Pivotal Eczema Trial With Extended Dosing
Apogee Therapeutics, Inc. rated Buy: zumilokibart Phase 2b AD results, 2–4 doses/yr, Blackstone $1.3B funding; fair value $82.97—read now. Click for an APGE update.…
Form 13G OnKure Therapeutics For: 27 May
Gyre Therapeutics COO Ye Weiguo sells $45,680 in stock
Outlook Therapeutics director Kurt J. Hilzinger buys $176,520 in stock
Secretome Therapeutics Announces $30 Million Series A Financing From RA Capital Management to Advance STM-01 for Duchenne-Associated Cardiomyopathy - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Nykode Therapeutics AS 2026 Q1 - Results - Earnings Call Presentation
2026-05-27. The following slide deck was published by Nykode Therapeutics AS in conjunction with their 2026 Q1 earnings call.…
Nykode Therapeutics AS (VACBF) Q1 2026 Earnings Call Transcript
Nykode Therapeutics AS (VACBF) Q1 2026 Earnings Call May 27, 2026 9:00 AM EDTCompany ParticipantsMichael Engsig - Chief Executive OfficerAgnete Fredriksen -...…
GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Jefferies upgrades PTC Therapeutics stock rating on Sephience outlook
Form 144 Rapport Therapeutics For: 27 May
Apogee Therapeutics secures $1.3 billion Blackstone financing deal, shares dive
Nocion Therapeutics Appoints Vineet Agarwal as Chief Business Officer - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…